User profiles for A. Agweyu
 | Ambrose AgweyuKEMRI-Wellcome Trust Research Programme Verified email at kemri-wellcome.org Cited by 1993 |
[HTML][HTML] Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review
Background An improved estimation of the clinical sequelae of SARS-CoV-2 infection is
crucial in African countries, where the subject has received little attention despite more than 12 …
crucial in African countries, where the subject has received little attention despite more than 12 …
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
…, AK Keita, A Kone, A Bouzid, A Souissi, A Agweyu… - Science, 2022 - science.org
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …
in Africa over the past year has led to a major increase in the number of sequences that have …
COVID-19 transmission dynamics underlying epidemic waves in Kenya
Policy decisions on COVID-19 interventions should be informed by a local, regional and
national understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
national understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
The effects of aflatoxin exposure on Hepatitis B-vaccine induced immunity in Kenyan children
…, SO Wandiga, C Mutegi, B Ogutu, A Agweyu… - Current problems in …, 2019 - Elsevier
Background: Globally, approximately three million children die each year from vaccine
preventable infectious diseases mainly in developing countries. Despite the success of the …
preventable infectious diseases mainly in developing countries. Despite the success of the …
[HTML][HTML] Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions
about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood …
about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood …
[HTML][HTML] An unsupported preference for intravenous antibiotics
… Ambrose Agweyu, … Citation: Li HK, Agweyu A, English M, Bejon P (2015) An
Unsupported Preference for Intravenous Antibiotics. PLoS Med 12(5): e1001825. https://doi.org/10.1371/journal.pmed.1001825 …
Unsupported Preference for Intravenous Antibiotics. PLoS Med 12(5): e1001825. https://doi.org/10.1371/journal.pmed.1001825 …
Employing learning health system principles to advance research on severe neonatal and paediatric illness in Kenya
We have worked to develop a Clinical Information Network (CIN) in Kenya as an early form
of learning health systems (LHS) focused on paediatric and neonatal care that now spans 22 …
of learning health systems (LHS) focused on paediatric and neonatal care that now spans 22 …
Seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 among healthcare workers in Kenya
Background Few studies have assessed the seroprevalence of antibodies against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCWs) …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCWs) …
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
Background A few studies have assessed the epidemiological impact and the cost-effectiveness
of COVID-19 vaccines in settings where most of the population had been exposed to …
of COVID-19 vaccines in settings where most of the population had been exposed to …
